“I need to get you to hit the market”…two different contrasts in blockbuster-level pharmaceutical products last year
Last year, blockbuster-level pharmaceutical products had different score sheets in the outpatient market.
The recent data of outpatient prescription expenses by UBIST analyzed multinational pharmaceutical companies’ products decreased more than KRW 5 billion.
First of all, the Gilead’s chronic ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
